Willem de Laat
Directeur Général chez LiGalli BV
Profil
Willem de Laat joined Organon International, Inc. in February 2006 and currently serves as Executive Vice President of Medical Affairs and Quality.
He is a Member of Supervisory Board for TNO and Technical University.
Prior to joining Organon International, Dr. de Laat worked with the Westeinde Hospital.
He received an MD from Radboud University, a PhD in Gynecology from Utrecht University, and an Executive MBA from Simon Business School, Rochester.
Postes actifs de Willem de Laat
| Sociétés | Poste | Début |
|---|---|---|
Organon International, Inc.
 Organon International, Inc. Pharmaceuticals: MajorHealth Technology Organon International, Inc. manufactures and markets pharmaceutical products. It develops therapeutics in the fields such as gynecology, fertility, osteoporosis, and anesthesia. The company was founded in 1923 and is located in Roseland, NJ. | Directeur Technique/Scientifique/R&D | 01/02/2006 |
| Technical University of Sofia | Corporate Officer/Principal | - |
LiGalli BV
 LiGalli BV Packaged SoftwareTechnology Services LiGalli BV is a Dutch company that focuses on women's health by providing personalized treatment through their innovative product, the MedRing. LiGalli is based in The Hague, NL, and aims to enhance the quality of life and care of women. The MedRing is a vaginal ring that is equipped with smart technology and biosensors to monitor and record data. It is clinically proven to successfully deliver a range of drugs through the vaginal mucosa and lasts for 28 days. The joint venture company was founded in 2014 by Willem de Laat, who has been the CEO since then. | Directeur Général | 01/01/2014 |
Anciens postes connus de Willem de Laat
| Sociétés | Poste | Fin |
|---|---|---|
Nederlandse Organisatie voor Toegepast-Natuurwetenschappelijk
 Nederlandse Organisatie voor Toegepast-Natuurwetenschappelijk Miscellaneous Commercial ServicesCommercial Services Nederlandse Organisatie voor Toegepast-Natuurwetenschappelijk provides scientific services. It includes research and consultancy for government, businesses and organizations. The company was founded in 1932 and is headquartered in Delft, Netherlands. | Directeur/Membre du Conseil | - |
Formation de Willem de Laat
| Rochester Christian University | Masters Business Admin |
| University of Utrecht | Doctorate Degree |
| Radboud University Nijmegen | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Nederlandse Organisatie voor Toegepast-Natuurwetenschappelijk
Nederlandse Organisatie voor Toegepast-Natuurwetenschappelijk Miscellaneous Commercial ServicesCommercial Services Nederlandse Organisatie voor Toegepast-Natuurwetenschappelijk provides scientific services. It includes research and consultancy for government, businesses and organizations. The company was founded in 1932 and is headquartered in Delft, Netherlands. | Commercial Services |
Organon International, Inc.
Organon International, Inc. Pharmaceuticals: MajorHealth Technology Organon International, Inc. manufactures and markets pharmaceutical products. It develops therapeutics in the fields such as gynecology, fertility, osteoporosis, and anesthesia. The company was founded in 1923 and is located in Roseland, NJ. | Health Technology |
LiGalli BV
LiGalli BV Packaged SoftwareTechnology Services LiGalli BV is a Dutch company that focuses on women's health by providing personalized treatment through their innovative product, the MedRing. LiGalli is based in The Hague, NL, and aims to enhance the quality of life and care of women. The MedRing is a vaginal ring that is equipped with smart technology and biosensors to monitor and record data. It is clinically proven to successfully deliver a range of drugs through the vaginal mucosa and lasts for 28 days. The joint venture company was founded in 2014 by Willem de Laat, who has been the CEO since then. | Technology Services |